Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-074358
Filing Date
2025-08-05
Accepted
2025-08-05 19:32:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7639
  Complete submission text file 0001104659-25-074358.txt   9455
Mailing Address PO BOX 7338 BERKELEY CA 94707
Business Address
ALAFI CAPITAL CO LLC (Filed by) CIK: 0001216017 (see all company filings)

EIN.: 943359302 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91725 | Film No.: 251186754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)